001360 — Samsung Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Market Cap
KR₩147bn
Enterprise Value
KR₩107bn
Revenue
KR₩52bn

Annual balance sheet for Samsung Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	29,906	29,031	64,402	55,986	4,281
Net Total Accounts Receivable
Net Total Receivables	18,677	13,918	10,082	7,491	6,890
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	61,394	65,312	85,390	69,571	29,454
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	82,876	92,214	31,460	26,644	26,152
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	168,532	178,726	145,456	117,915	93,479
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22,269	50,190	16,697	14,233	12,818
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	25,703	56,811	18,186	15,325	15,894
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	142,829	121,915	127,270	102,590	77,585
Total Liabilities & Shareholders' Equity	168,532	178,726	145,456	117,915	93,479
Total Common Shares Outstanding